G-protein inwardly rectifying potassium channel 1 (GIRK 1) gene expression correlates with tumor progression in non-small cell lung cancer

BMC Cancer

Volumn 4, Issue , 2004, Pages

  Takanami, Iwao ^a   Inoue, Yoshimasa ^a   Gika, Masatoshi ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; INWARDLY RECTIFYING POTASSIUM CHANNEL; AMFR PROTEIN, HUMAN; AUTOCRINE MOTILITY FACTOR RECEPTOR; CYTOKINE RECEPTOR; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL; KCNJ3 PROTEIN, HUMAN; UBIQUITIN PROTEIN LIGASE;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; SURVIVAL RATE; ADENOCARCINOMA; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; LYMPH NODE; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; SQUAMOUS CELL CARCINOMA; SURVIVAL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RECEPTORS, AUTOCRINE MOTILITY FACTOR; RECEPTORS, CYTOKINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL ANALYSIS; UBIQUITIN-PROTEIN LIGASES;

EID: 13144285681     PISSN: 14712407     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2407-4-79     Document Type: Article

References (21)

1. Ginsberg R, Vokes E, Raben A: Non-small cell lung cancer. In In: Cancer : principles and practice of oncology Edited by: deVita V, Helleman S. Rosenberg S. Philadelphia: Lippencott-Raven; 1997:858-911.
2. Nesbitt JC, Putnum JB Jr, Walsh GL, Roth JA, Mountain CF: Survival in early-stage non-small cell lung cancer. Ann Thoracic Surg 1995, 60:466-472.
3. Minna JD: The molecular biology of lung cancer pathogenesis. Chest 1993, 103:449S-56S.
4. Birrer MJ, Brown PH: Application of molecular genetics to the early diagnosis and screening of lung cancer. Cancer Res 1992, 52:2658S-2664S.
5. Harpole DH, Herndon JE, Wolfe WG, Igrehart JD, Marks JR: A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression. Cancer Res 1995, 55:51-6.
6. Schoots O, Yue KT, MacDonald JF, Hampson DR, Nobrega JN, Dixon LM, Van Tol HH: Cloning of a G protein-activated inwardly rectifying potassium channel from cerebellum. Brain Res Mol Brain Res 1996, 39:23-30.
7. Kubo Y, Reuveny E, Slesinger PA, Yan YN, Jan LY: Primary structure and functional expression of a rat G-protein-coupled muscarinic potassium channel. Nature 1993, 364:802-806.
8. Stringer BK, Cooper AG, Shepard SB: Overexpression of the G-protein inwardly rectifying potassium channel 1 (GIRK1) in primary breast carcinomas correlated with axillary lymph node metastasis. Cancer Res 2001, 61:582-588.
9. International Union Against Cancer. TNM classification of malignant tumors 5th edition. Edited by: Sobin LH, Witlekind CH. New York; John Wiley; 1997.
10. Chomczynski P, Saechi N: Single step method of RNA isolation by asid guanidinium thiocyante-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159.
11. Gartel AL, Serfas MS, Gartel M, Goufman E, Wu GS, el-Deiry WS, Tyner AL: p21 (WAF1/CIP1) expression is induced in newly nondividing cells in diverse epithelia and during differentiation of the Caco-2 intestinal cell line. Exp Cell Res 1996, 227: 71-181.
12. Takanami I, Takeuchi K, watanabe H, Yanagawa T, Takagishi K, Raz A: Significance of autocrine motility factor gene expression as a prognostic factor in non-small-cell lung cancer. Int J Cancer 2001, 95:384-387.
13. Landis SH, Murray T, Bolden S, Wingo PA: Cancer statistics. CA Cancer J Clin 1998, 48:6-29.
14. Marino AA, Iliev IG, Schwalke MA, Gonzalez E, marler KC, Flonagen CA: Association between cell membrane potential and breast cancer. Tumour Biol 1994, 15:82-89.
15. Woodrough RE, Canti G, Watson BW: Electrical potential difference between basal cell carcinoma, benign inflammatory lesions and normal tissue. Br J Dermatol 1975, 92:1-7.
16. Takahashi A, Yamaguchi H, Miyamoto H: Change in density of K+ current of HeLa cells during the cell cycle. Jpn J Physiol 1994, 44:S321-S324.
17. Hanahan D, Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996, 86: 53-364.
18. Guidi AJ, Berry DA, Broadwater G, perloff M, Norton L, Barcos MP, Hayes DF: Association of angiogenesis in lymph node metastases with outcome of breast cancer. J Natl Cancer Inst 2000, 15: 86-492.
19. Jaeger TM, Weidner N, chew K, Moore DH, Kerschmann RL, Waldman FM, Carroll PR: Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer. J Urol 1995, lymph node metastases in invasive bladder cancer. J Urol 1995, 154: 9-71.
20. Blakwell KL, Dewhirst MW, Liotcheva V, Snyder S, Broadwater G, Bentley R, Lal A, Riggins G, Anderson S, Vredenburgh G, Proia A, Harris LN: Her2 gene amplification correlates with higher levels of angiogenesis and lower levels of hypoxia in primary breast tumors. Clin Cancer Res 2004, 10:4083-4088.
21. Takanami I, Takeuchi K, Giga M: The prognostic value of natural killer vell infiltration in resected pulmonary adenocarcinoma. J Thorac Cardiovasc Surg 2001, 121:1058-1063.